Chemotherapy-induced hand-foot syndrome among Chinese inpatients: a qualitative descriptive study in Shanghai
Open Access
Abstract
Objective: To explore the symptom experiences and self-management strategies of patients with chemotherapy-induced hand-foot syndrome (HFS), and to identify approaches for improving symptom control and quality of life. Design: A qualitative study using semi-structured interviews and thematic analysis. Setting: We conducted this study in the oncology inpatient ward of a tertiary hospital in Shanghai, China. Participants: We used a purposive sampling approach to recruit 25 inpatients with chemotherapy-induced HFS from July 2022 to March 2024. The interviews were audio-recorded and transcribed verbatim. We employed an adapted version of Colaizzi’s qualitative analysis approach to examine the data. Results: 25 patients (mean age 58 years; 56% male) with grade I–III chemotherapy-induced HFS were interviewed. Four inter-related themes emerged. (1) Symptom experience: pain, numbness and burning sensations disturbed sleep; visible peeling and hyper-pigmentation triggered embarrassment and self-consciousness. (2) Emotional responses: most participants accepted symptoms as ‘part of treatment’, yet persistent anxiety about progression and guilt over becoming a family burden were common. (3) Social impact: patients avoided outdoor activities, stopped caring for grandchildren and reported lost income because ‘hands can’t touch cold or rough items’. (4) Future expectations: participants wanted pictorial self-care guides, a nurse hotline after discharge and earlier introduction of pain-relief strategies. All expressed frustration at ‘no-one to ask’ once home. Conclusions: Chemotherapy-induced HFS imposes a considerable multidimensional burden. Tailored, patient-centred interventions that integrate education, psychological support and family involvement are essential to improve symptom management and overall well-being. Future work should develop and test sustainable, long-term support strategies in broader populations. Scientific and clinical significance: This study provides the first qualitative evidence base for understanding and managing chemotherapy-induced HFS in Chinese patients, informing nurse-led interventions, patient-reported outcome development and national supportive-care policy.Keywords
Funding Information
- Nursing Department of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China (RJHK-2023-16)
This publication has 33 references indexed in Scilit:
- Advancements in the diagnosis and management of capecitabine-induced hand-foot syndromeJournal of Cancer Research and Clinical Oncology, 2025
- The Impact of Dermatologic Adverse Events on the Quality of Life of Oncology Patients: A Review of the LiteratureAmerican Journal of Clinical Dermatology, 2024
- Early symptom recognition and symptom management among exacerbation COPD patients: A qualitative studyApplied Nursing Research, 2022
- Pyridoxine for prevention of hand–foot syndrome caused by chemotherapy agents: a meta‐analysisClinical and Experimental Dermatology, 2020
- Effect of urea cream on sorafenib-associated hand–foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled studyEuropean Journal of Cancer, 2020
- Adverse cutaneous reactions to chemotherapeutic drugsClinics in Dermatology, 2020
- Evaluation of patient-reported severity of hand–foot syndrome under capecitabine using a Markov modeling approachCancer Chemotherapy and Pharmacology, 2020
- The quality of quality criteria: Replicating the development of the Consolidated Criteria for Reporting Qualitative Research (COREQ)International Journal of Nursing Studies, 2020
- Unmet needs of cancer patients with chemotherapy-related hand-foot syndrome and targeted therapy-related hand-foot skin reaction: A qualitative studyEuropean Journal of Oncology Nursing, 2019
- Regorafenib-associated hand–foot skin reaction: practical advice on diagnosis, prevention, and managementAnnals of Oncology, 2015